Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation

Launched by UNIVERSITY OF ALBERTA · Jun 21, 2016

Keywords

ClinConnect Summary

This clinical trial is looking at how certain tests can help doctors better understand and manage lung transplant rejection. Specifically, the study focuses on using a technique called molecular phenotyping to examine tissue samples taken from lung transplant patients who are experiencing problems with their transplanted lung. The goal is to see if this method can provide useful information to improve patient care and to explore a new, safer way to collect tissue samples from the lungs.

To participate in this trial, you need to be a lung transplant recipient who is undergoing a biopsy, which is a procedure where a small sample of tissue is taken for testing. The study is open to all adults, and the research team is currently recruiting participants. If you join, you can expect to undergo the usual biopsy process, and the researchers will analyze the samples to gather important data that could benefit future patients. It’s important to know that if you choose not to participate or if you cannot provide consent, you won’t be eligible for this study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All lung transplant recipients undergoing a biopsy as determined by their surgeon or physician.
• Exclusion Criteria:
• • Patients who declined participation or unable to give informed consent.